Study of Multiple Oral Doses of Odanacatib (MK0822) in Healthy Adults (0822-002)
Clinical trial NCT00769418 · COMPLETED
Trial details
- NCT number
- NCT00769418
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2004-09-01
- Primary completion
- 2004-12-01
- Enrollment
- 62
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.